Lipid-Based Nutritional Suplement – Small Quantity (LNS-SQ)
Nutriset
Solution Overview & Benefits
Lipid-based nutritional supplements – Small Quantity (LNS-SQ) such as Enov’Nutributter®+ have joined the list of internationally recognised most effective nutritional interventions to improve infant nutrition (Lancet, 2021).
In populations where infant undernutrition is prevalent and where the quality of the diet is inadequate, Enov’Nutributter®+ helps to compensate for the deficiencies in the complementary diet. It provides all the micronutrients (minerals and vitamins) and essential fatty acids needed for children’s growth.
Given with the complementary food to children aged 6-23 months, Enov’Nutributter®+ reduces :
- stunting by 12% and less severe stunting by 17%,
- wasting by 14% and severe wasting by 31%,
- anaemia by 16% and iron deficiency anaemia by 64%,
- developmental delays by 16-19%,
- and the risk of all-cause mortality by 27%.
Enov’Nutributter®+ does not interfere with breastfeeding or complementary feeding.
History & Development
Nutriset was the first company to develop therapeutic milks for the treatment of malnutrition and is best known for developing Plumpy’Nut®, the first peanut-based ready-to-use therapeutic food (RUTF) for the treatment of severe acute malnutrition (SAM) – a life-threatening form of hunger that now affects nearly 20 million children under the age of five around the world.
Availability
- Publicly available: yes
- Countries where available: Worldwide
- Price range (USD): Contact supplier for quote
Similar solutions...
Get in Touch!
Get in touch with us by filling out the form or emailing us at contact@techxlab.org.
